Cargando…
Recombinant BCG Expressing LTAK63 Adjuvant induces Superior Protection against Mycobacterium tuberculosis
In order to develop an improved BCG vaccine against tuberculosis we have taken advantage of the adjuvant properties of a non-toxic derivative of Escherichia coli heat labile enterotoxin (LT), LTAK63. We have constructed rBCG strains expressing LTAK63 at different expression levels. Mice immunized wi...
Autores principales: | Nascimento, Ivan P., Rodriguez, Dunia, Santos, Carina C., Amaral, Eduardo P., Rofatto, Henrique K., Junqueira-Kipnis, Ana P., Gonçalves, Eduardo D. C., D’Império-Lima, Maria R., Hirata, Mario H., Silva, Celio L., Winter, Nathalie, Gicquel, Brigitte, Mills, Kingston H. G., Pizza, Mariagrazia, Rappuoli, Rino, Leite, Luciana C. C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5437048/ https://www.ncbi.nlm.nih.gov/pubmed/28522873 http://dx.doi.org/10.1038/s41598-017-02003-9 |
Ejemplares similares
-
Recombinant BCG-LTAK63 Vaccine Candidate for Tuberculosis Induces an Inflammatory Profile in Human Macrophages
por: dos Santos, Carina C., et al.
Publicado: (2022) -
Recombinant BCG expressing the LTAK63 adjuvant induces increased early and long-term immune responses against Mycobacteria
por: Carvalho Dos Santos, Carina, et al.
Publicado: (2019) -
Recombinant BCG expressing the LTAK63 adjuvant improves a short-term chemotherapy schedule in the control of tuberculosis in mice
por: Trentini, Monalisa Martins, et al.
Publicado: (2022) -
Recombinant BCG expressing the LTAK63 adjuvant increased memory T cells and induced long-lasting protection against Mycobacterium tuberculosis challenge in mice
por: Marques-Neto, Lázaro Moreira, et al.
Publicado: (2023) -
CRISPR/Cas9 Approach to Generate an Auxotrophic BCG Strain for Unmarked Expression of LTAK63 Adjuvant: A Tuberculosis Vaccine Candidate
por: Moraes, Luana, et al.
Publicado: (2022)